Novel Therapeutic Strategies and Drug Innovations with Anti-Neuroinflammatory Potential in Neurological Disorders
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 31 December 2026 | Viewed by 67
Special Issue Editors
Interests: nanotechnology; nanobiochemistry; cancer research; inflammation reseach; nervous system central; biotechnology; drug delivery system
Special Issues, Collections and Topics in MDPI journals
Interests: drugs; inflammation; neuropsychopharmacology; drug toxicity; pharmacokinetic properties; medicinal chemistry; drug design; drugs delivery
Special Issue Information
Dear Colleagues,
Neuroinflammation is increasingly recognized as a pivotal mechanism in the onset and progression of a broad range of neurological disorders, including neurodegenerative diseases, cerebrovascular pathologies, traumatic brain injury, and neuropsychiatric conditions. Persistent activation of neuroimmune pathways, glial dysregulation, oxidative stress, and blood–brain barrier dysfunction play critical roles in neuronal damage and functional decline. Consequently, targeting neuroinflammatory processes has become a promising strategy for therapeutic intervention beyond conventional symptomatic treatments. This Special Issue aims to showcase recent advances in novel therapeutic strategies and drug innovations with anti-neuroinflammatory potential. Contributions may encompass the rational development of new drug candidates, innovative drug delivery systems designed to enhance brain targeting and therapeutic efficacy, as well as investigative and mechanistic approaches that elucidate molecular, cellular, and signaling pathways involved in neuroinflammation. Studies employing in silico, in vitro, in vivo, and translational frameworks are encouraged. By integrating drug development, delivery technologies, and mechanistic insights, this Special Issue seeks to promote interdisciplinary research and accelerate the translation of anti-neuroinflammatory strategies into effective treatments for neurological disorders.
Prof. Dr. Francisco Humberto Xavier-Júnior
Dr. Pablo Rayff da Silva
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuroinflammation
- neurological disorders
- drug development
- drug delivery systems
- therapeutic mechanisms
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
